An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models. - Moore CC; Martin EN; Lee GH; Obrig T; Linden J; Scheld WM; Moore, Christopher C; Martin, Edward N; Lee, Grace H; Obrig, Tom; Linden, Joel; Scheld, W Michael (BMC Infectious Diseases, 2008)